Navigation Links
Beckman Coulter Announces Third Quarter 2008 Results
Date:10/28/2008

ncluding three additional work cells, support positive momentum. Launch of the DxH 800, next-generation cellular analysis system, and accelerating growth from our newly acquired flow cytometry products should sustain Cellular Analysis gains. While no company is fully insulated from vulnerable and volatile world markets, we expect strong growth of total and recurring revenue and continuing focus on operating excellence to drive delivery of our EPS objectives," Garrett concluded.

Investor Conference Call

As previously announced, there will be a conference call today, Tuesday, October 28, 2008 at 5:00 pm ET to discuss the third quarter ended September 30, 2008 results. The call will also be webcast live. The call is accessible to all investors through Beckman Coulter's website at http://www.beckmancoulter.com or at http://www.streetevents.com. When accessing the webcast through the Beckman Coulter site, select "go to IR" under Investor Relations and find the call listed under "What's Ahead." The webcast will be archived on both websites for future on-demand replay through Friday, November 15, 2008.

About Beckman Coulter

Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78% of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Forward-Looking Statements

This press release contains forward-looking statements with
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference
2. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
3. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
4. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
5. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
6. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
7. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
8. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
9. Align Technology Announces Third Quarter Fiscal 2008 Results
10. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
11. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... to a study published today in PLOS Pathogens ... where malaria is common can mount an immune response ... to avoid repeated bouts of high fever and illness ... their bloodstream. The findings may help researchers develop future ... the malaria parasite. , Each year, approximately 200 million ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease is ... may be mistaken for foreign invaders and killed by ... autoimmune diseases like type I diabetes, celiac disease, and ... published April 16, 2014, in Nature Communications . ... in Parkinson,s disease; but if true, it could lead ...
(Date:4/17/2014)... team led by researchers at UC Davis has shown ... key role in cell division, also boosts the mitochondrial ... time the complex has been shown to perform both ... excellent target to control cellular energy production, potentially advancing ... online today in the journal Developmental Cell . ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
... 25, 2007) George Mason University professor of ... grant from the National Institutes of Health to ... Alzheimer,s disease. His program, "Apolipoprotein, Attention and Alzheimer,s ... and older adults for four years using cognitive, ...
... The Partnership to,Fight Chronic Disease (PFCD) announced today ... all 2008 presidential candidates to address the,country,s chronic disease ... reform will be the most important domestic issue in ... and,Professor and Chair of the Rollins School of Public ...
... National Marrow Donor Program,s Office of Patient Advocacy receives ... to help cancer survivors like Ryan, MINNEAPOLIS, Sept. 25 ... most of his life. Diagnosed with acute,myelogenous leukemia at just ... marrow or cord blood transplant to survive. Ryan received ...
... the, importance of staying active and eating healthy ... Calif., Sept. 25 Blue Cross of,California, collaborating ... Sports, is launching a 14-week statewide mobile,outreach campaign ... to make,healthy lifestyle choices now and in the ...
... Natural Cottage Cheese and NBC 10 Seek the Next Local ... in This Year,s Healthy Lifestyle ... massage,therapist, a 35-year-old administrative assistant, a 41-year-old comedian,and computer help ... teacher have in common? They,re all contestants in,"The Friendship All ...
... results from the randomized, double -blind,placebo -controlled, Phase ... of ZD4054 - a,specific endothelin A (ETA) receptor ... European,Congress of Clinical Oncology (ECCO, 23-27 September, Barcelona). ... in development for the treatment of men with ...
Cached Medicine News:Health News:George Mason University professor receives $2.6 million NIH grant to study Alzheimer's disease 2Health News:Partnership to Fight Chronic Disease Announces 'Ideas for Change' in Health Care 2Health News:Partnership to Fight Chronic Disease Announces 'Ideas for Change' in Health Care 3Health News:Young Twin Cities Boy Shows There is Life After Cancer 2Health News:Blue Cross of California and the California Governor's Council on Physical Fitness and Sports Launch 'Live Like a Champion Tour' 2Health News:Blue Cross of California and the California Governor's Council on Physical Fitness and Sports Launch 'Live Like a Champion Tour' 3Health News:Five Local Residents Vie to be Philadelphia's Biggest 2007 'Local Loser' 2Health News:Five Local Residents Vie to be Philadelphia's Biggest 2007 'Local Loser' 3Health News:Five Local Residents Vie to be Philadelphia's Biggest 2007 'Local Loser' 4Health News:Survival data presented from phase II study of hormone-resistant prostate cancer patients 2
(Date:1/15/2014)... BOSTON , Jan. 15, 2014 Tegra Medical is ... Mark King as its new Chief Executive Officer.  Mark ... in which he has overseen the company,s four facilities in ... and Costa Rica.  Mr. King joined Tegra Medical in 2012 ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis ... results from two pre-clinical studies that,support the ... rich in,cysteine) expression in cancer and Abraxis' ... Association for Cancer Research (AACR) Annual Meeting ...
... Transurethral Resection,is Well Tolerated in Phase 2b Bladder ... --,Spectrum Pharmaceuticals, Inc., today announced results of a ... and the,presentation of preclinical data of SPI (IRL)-1620 ... Association of Cancer,Research, held at the Los Angeles ...
Cached Medicine Technology:Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8
Curved to the Left 9# with 30 cm long silicone tubing with connector; 40mm overall length; in stainless steel...
... Cordis biopsy forceps are designed for endomyocardial biopsies. ... consist of a 3-pull ring handle, stainless steel ... thumb ring rotates to accommodate any position. ,A ... closed. The jaws are opened by moving the ...
4-Strand Basket Retriever was developed to facilitate recovery of foreign objects from within the neuro, peripheral, and cardiovasculature, the In-Time Retrieval Device features an integrated corewir...
... non-invasive, virtually pain-free alternative to conventional open ... indications. With Leksell Gamma Knife C the ... improves the ability to mould the radiation ... allows a more selective irradiation and thus ...
Medicine Products: